Technical Specifications
| Drug Composition | Secukinumab 150 mg Injection |
|---|---|
| Variant / Strength | 150 mg |
| Dosage Form / Type | Injectables |
| Product Benefits | Ankylosing spondylitis & Psoriasis, Treatment of Psoriatic arthritis |
| Packaging Type | Vial |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
| Export Destinations | USA, UK, UAE, Philippines, Thailand, Kenya, Nigeria, Germany, Canada, Mexico, and 65+ more countries |
| Export Route | Shipped via temperature-controlled international air courier with full customs documentation |
Product Overview & Description
Secukinumab 150 mg Injection is employed for the treatment of diverse conditions, including psoriatic arthritis, ankylosing spondylitis, and psoriasis. It alleviates symptoms such as swelling, pain, and redness associated with these disorders, thereby enhancing physical function.
Administered by a healthcare professional, self-administration of Secukinumab 150 mg Injection is not recommended. It is advised to use it consistently at the same time daily to maximize its benefits. The patient should adhere to the prescribed regimen, continuing its use as directed by the doctor and completing the full course of treatment even if improvement is observed.
Submit Quotation Request
Verified Customer Reviews (0)
Frequently Asked Questions
ℹ️ Information reviewed by Medibliss Lifesciences Editorial Team. Last reviewed: August 2026. Data sourced from manufacturer documentation and WHO-GMP certificates.
Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Medibliss Lifesciences acts solely as an exporter and supplier. Please consult your physician or a qualified healthcare provider before starting any medication. We do not manufacture these products and rely on the manufacturer's provided documentation and WHO-GMP certifications for product information.